Role of Tissue Inhibitor of Metalloproteinase-2 in Human Cardiac Fibroblast-Mediated Extracellular Matrix Remodeling
Date
2013-04-30
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
After a myocardial infarction, extracellular matrix (ECM) dysregulation leads to maladaptive cardiac remodeling that constitutes the basis of development of heart failure. Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) is an endogenous biomolecule that is critical in the maintenance of ECM architecture. Cardiac fibroblasts are the main cell type that regulates ECM homeostasis. This study employed an innovative method of three-dimensional collagen gel assay, which mimics the natural in vivo ECM. We investigated the effect of TIMP-2 on the human cardiac fibroblast-mediated ECM remodeling. TIMP-2 induced differentiation of cardiac fibroblasts into myofibroblasts that are active in collagen synthesis. Concurrently, TIMP-2 induced an increase in the total protease activity within the collagen gel microenvironment. TIMP-2 did not promote a fibrotic response, despite its ability to activate myofibroblasts. These actions appear to be independent of its MMP-inhibitory actions. In conclusion, TIMP-2 promotes ECM homeostasis via simultaneous induction of myofibroblast activation and total protease activity.
Description
Keywords
Medicine and Surgery
Citation
Ngu, J. (2013). Role of Tissue Inhibitor of Metalloproteinase-2 in Human Cardiac Fibroblast-Mediated Extracellular Matrix Remodeling (Master's thesis, University of Calgary, Calgary, Canada). Retrieved from https://prism.ucalgary.ca. doi:10.11575/PRISM/27687